Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$7,130,401
+$584,953 QoQ
Shares Held
296,113
+27.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#502
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HENNESSY ADVISORS INC holds $74,827,284 across 8 Drug Manufacturers - General names. PFE ranks #5 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
114,850 | $14,758,225 | |
| 2 | JNJ |
Johnson & Johnson
|
49,300 | $12,520,721 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
85,199 | $10,764,041 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
163,850 | $9,441,037 | |
| 5 | PFE |
Pfizer Inc
This page
|
296,113 | $7,130,401 | |
| 6 | AMGN |
Amgen Inc
|
19,120 | $6,923,734 | |
| 7 | ABBV |
AbbVie Inc.
|
27,300 | $6,869,772 | |
| 8 | GSK |
GSK plc
|
122,460 | $6,419,353 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,130,401 | 296,113 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $6,545,448 | 233,100 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $4,833,090 | 194,100 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $5,220,852 | 204,900 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $5,044,344 | 208,100 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $5,273,254 | 208,100 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $4,610,914 | 173,800 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $5,212,094 | 180,100 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $5,039,198 | 180,100 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $5,100,450 | 183,800 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $5,141,894 | 178,600 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $6,149,718 | 185,400 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $6,954,528 | 189,600 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $8,098,800 | 198,500 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $5,574,912 | 108,800 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $4,848,608 | 110,800 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $5,746,328 | 109,600 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,673,992 | 109,600 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,847,745 | 132,900 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $5,849,360 | 136,000 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $5,407,996 | 138,100 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $5,179,078 | 142,950 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $6,585,309 | 178,900 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $8,925,431 | 243,200 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $8,896,044 | 272,050 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $9,165,299 | 280,800 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||